Abstract
The radiochemical separation of n.c.a. arsenic on its own or for radio-labelling purposes usually involves the issue of reducing arsenic(V). Numerous approaches for reducing pentavalent arsenic have been examined. A novel HPLC method has also been presented for accessing the efficiency of the reduction in terms of *As(III)/*As(V). Labelling with trivalent radioarsenic seems to be a promising research field to access new radiopharmaceuticals, for example, using arsenic as a surrogate for phosphorus. Moreover, as a model system, the labelling reaction of *As(III) with dihydrolipoic acid has been systematically optimized.
Original language | English (US) |
---|---|
Pages (from-to) | 75-82 |
Number of pages | 8 |
Journal | Applied Radiation and Isotopes |
Volume | 149 |
DOIs | |
State | Published - Jul 2019 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was partly and jointly supported by NKFI (Hungary, grant TET_12_DE-I-2013-0013 ) and BMBF (Germany, grant 01DS14024 ).
Funding Information:
We thank to Prof. Dr. B. Neumaier and Dr. I. Spahn from the Research Centre Jülich, Institute for Neurosciences and Medicine, section Nuclear Chemistry (INM-5), for providing proton irradiated nat.GeO2 pellets containing 74As. This work was partly and jointly supported by NKFI (Hungary, grant TET_12_DE-I-2013-0013) and BMBF (Germany, grant 01DS14024).
Publisher Copyright:
© 2019